ACTIVE

Türmchen

Financial year 2025 · closed on 31/12/2025
Gross margin
129,6 k €
+3.5% YoY
Equity
15 k €
0.0% YoY
Workforce
1,6 ETP
-5.9% YoY

What does Türmchen do?

Türmchen is a Private limited company incorporated in 2023. Its main activity is: General medical practice activities. Its registered office is in Eupen. It employs on average 1,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0801.836.840
Incorporation
16/05/2023
Legal form
Private limited company
Registered office
von Asten-Straße 39
4701 Eupen · WallonieSee on map
Contributed capital
15 000,00 €
Latest accounts
31/12/2025
Average workforce
1,6 ETP
Signals
ProfitablePositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202520242023
Income statement
Gross margin129,6 k €125,2 k €45,2 k €
EBITDA8,7 k €2,1 k €604,9 €
Operating result218,4 €571,5 €213,3 €
Balance sheet
Equity15 k €15 k €15 k €
Total assets204,1 k €428 k €146,9 k €
Cash108,5 k €377,2 k €55,4 k €
Debts189,1 k €413 k €131,9 k €
Other
Workforce1,6 ETP1,7 ETP1,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active

Active mandates

DR ADRIAAN OOMEN

Director · since 16 mai 2023 · 0668.788.967

Represented by Adriaan OOMEN

Active
Dr RICHTER DAMIAN

Director · since 16 mai 2023 · 0738.821.779

Represented by Damian RICHTER

Active
MEDIFRY

Director · since 16 mai 2023 · 0774.898.455

Represented by Guillaume FRYNS

Active
At this address

Other companies at this address

CompanyCBE no.
0668.788.967
Annual accounts

Full financial information

202520242023
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202416/05/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months8 months
Filing date25/08/202629/07/202504/07/2024
General meeting30/06/202606/06/202531/05/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202625/08/2026GermanPDF
Abridged model31/12/202406/06/202529/07/2025GermanPDF
Abridged model31/12/202331/05/202404/07/2024GermanPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active

Active mandates

DR ADRIAAN OOMEN

Director · since 16 mai 2023 · 0668.788.967

Represented by Adriaan OOMEN

Active
Dr RICHTER DAMIAN

Director · since 16 mai 2023 · 0738.821.779

Represented by Damian RICHTER

Active
MEDIFRY

Director · since 16 mai 2023 · 0774.898.455

Represented by Guillaume FRYNS

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other19/05/2023
    RUBRIK GRUENDUNG (NEUE RECHTSPERSON, EROEFFNUNG FILIALE, USW)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025
  2. 2024
    Annual accounts 2024
  3. 2023
    Annual accounts 2023
  4. 16/05/2023
    IncorporationPrivate limited company